[The Lewis antigen system as a marker of IHD risk]. 1997

B B Zhiburt, and A I Chepel', and N B Serebrianaia, and N V Mineeva, and G P Ignatovich, and Iu A Shcherbak, and N E Ulanov

Prevalence of Lewis antigens and phenotypes has been investigated in 60 healthy donors and 74 patients with ischemic heart disease. It was found that phenotype Le(a-b-) marks high risk and phenotype Le(a-b+) is a resistance marker for development of ischemic heart disease. It would be valid to elucidate relationships between Lewis system and pathogenesis of internal diseases.

UI MeSH Term Description Entries
D007983 Lewis Blood Group Antigens Carbohydrate antigens structurally related to the ABH BLOOD-GROUP SYSTEM. They may occur as a modification of saccharide chains on glycolipids or glycoproteins on cell surfaces or in plasma, or as free oligosaccharides in secretions. Lewis antigens are not synthesized in blood cells. Instead Lewis glycolipids present in plasma are absorbed onto the surface of ERYTHROCYTES; LYMPHOCYTES; and PLATELETS. The phenotypes Le(a) and Le(b) are the result of the actions of two genes the Le gene (fucosyltransferase FUT3) and the Se gene (fucosyltransferase FUT2) on the precursor carbohydrate, glycolipid or glycoprotein. Other FUCOSYLTRANSFERASES can also synthesize the Lewis antigens. Blood Group Lewis Related Antigens,Lewis Antigen Related Tumor-Associated Antigens,Lewis Antigens,Lewis Blood Group Related Antigens,Lewis Blood Group Related Tumor-Associated Antigens,Lewis Blood-Group System,Lewis Related Antigens,Lewis System,Sialyl Lewis Antigens,Le Antigens,Le(a) Blood Group System,Antigens, Lewis,Antigens, Lewis Related,Antigens, Sialyl Lewis,Blood-Group System, Lewis,Lewis Antigen Related Tumor Associated Antigens,Lewis Blood Group Related Tumor Associated Antigens,Lewis Blood Group System
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D010641 Phenotype The outward appearance of the individual. It is the product of interactions between genes, and between the GENOTYPE and the environment. Phenotypes
D001782 Blood Donors Individuals supplying blood or blood components for transfer to histocompatible recipients. Blood Donor,Donor, Blood,Donors, Blood
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D012307 Risk Factors An aspect of personal behavior or lifestyle, environmental exposure, inborn or inherited characteristic, which, based on epidemiological evidence, is known to be associated with a health-related condition considered important to prevent. Health Correlates,Risk Factor Scores,Risk Scores,Social Risk Factors,Population at Risk,Populations at Risk,Correlates, Health,Factor, Risk,Factor, Social Risk,Factors, Social Risk,Risk Factor,Risk Factor Score,Risk Factor, Social,Risk Factors, Social,Risk Score,Score, Risk,Score, Risk Factor,Social Risk Factor
D012426 Russia A country located in north Asia bordering the Arctic Ocean, extending from Europe (the portion west of the Urals) to the North Pacific Ocean. The capital is Moscow. Russian S.F.S.R.,Russian Federation (Europe),Russian SFSR

Related Publications

B B Zhiburt, and A I Chepel', and N B Serebrianaia, and N V Mineeva, and G P Ignatovich, and Iu A Shcherbak, and N E Ulanov
August 1986, Gan to kagaku ryoho. Cancer & chemotherapy,
B B Zhiburt, and A I Chepel', and N B Serebrianaia, and N V Mineeva, and G P Ignatovich, and Iu A Shcherbak, and N E Ulanov
February 1990, The Journal of urology,
B B Zhiburt, and A I Chepel', and N B Serebrianaia, and N V Mineeva, and G P Ignatovich, and Iu A Shcherbak, and N E Ulanov
November 1980, Circulation,
B B Zhiburt, and A I Chepel', and N B Serebrianaia, and N V Mineeva, and G P Ignatovich, and Iu A Shcherbak, and N E Ulanov
March 1991, Cancer,
B B Zhiburt, and A I Chepel', and N B Serebrianaia, and N V Mineeva, and G P Ignatovich, and Iu A Shcherbak, and N E Ulanov
January 1974, Vox sanguinis,
B B Zhiburt, and A I Chepel', and N B Serebrianaia, and N V Mineeva, and G P Ignatovich, and Iu A Shcherbak, and N E Ulanov
June 1979, Zeitschrift fur Immunitatsforschung. Immunobiology,
B B Zhiburt, and A I Chepel', and N B Serebrianaia, and N V Mineeva, and G P Ignatovich, and Iu A Shcherbak, and N E Ulanov
July 2003, The American journal of surgical pathology,
B B Zhiburt, and A I Chepel', and N B Serebrianaia, and N V Mineeva, and G P Ignatovich, and Iu A Shcherbak, and N E Ulanov
June 1992, Cancer research,
B B Zhiburt, and A I Chepel', and N B Serebrianaia, and N V Mineeva, and G P Ignatovich, and Iu A Shcherbak, and N E Ulanov
June 1982, FEBS letters,
B B Zhiburt, and A I Chepel', and N B Serebrianaia, and N V Mineeva, and G P Ignatovich, and Iu A Shcherbak, and N E Ulanov
January 2003, Indian journal of clinical biochemistry : IJCB,
Copied contents to your clipboard!